HYPOVOLEMIC SHOCK

Clinical trials for HYPOVOLEMIC SHOCK explained in plain language.

Never miss a new study

Get alerted when new HYPOVOLEMIC SHOCK trials appear

Sign up with your email to follow new studies for HYPOVOLEMIC SHOCK, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1 Completed 1

Breakthrough drug trial aims to save lives from fatal blood loss shock

Disease control Recruiting now

This study is testing the safety and effectiveness of a new drug called LYFAQUIN (centhaquine citrate) for people with life-threatening shock caused by severe blood or fluid loss. About 400 adult patients with very low blood pressure will receive LYFAQUIN in addition to all stand…

Matched conditions: HYPOVOLEMIC SHOCK

Phase: PHASE4 • Sponsor: Pharmazz, Inc. • Aim: Disease control

Last updated Apr 02, 2026 05:56 UTC

HYPOVOLEMIC SHOCK

Get alerted when new HYPOVOLEMIC SHOCK trials appear

Breakthrough drug trial aims to save lives from fatal blood loss shock